Keywords: first, phase, ii, data, argatroban, ami, texas

First Phase II Data With Argatroban In AMI

Article | 28 October 1996

Texas Biotechnology has presented the preliminary results from the first of its three multicenter studies of Novastan (argatroban), a direct ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in